In infarct-related cardiogenic shock, immediate revascularization reduces mortality. For patients with multivessel coronary ...
The American Heart Association has created new registry will help researchers, clinicians and regulators to better understand the clinical symptoms of shock types, treatment patterns and outcomes. The ...
Background Cardiogenic shock (CS) complicating acute myocardial infarction (AMI) carries high mortality. Early ...
First released in 2019, the Society for Cardiovascular Angiography and Interventions (SCAI) cardiogenic shock categories have gotten a rethink, one that adds nuance to aid decision-making and ...
UC San Francisco’s Heart and Vascular Center has been recognized by the American Heart Association (AHA) for its participation in a new Cardiogenic Shock Registry. The purpose of the registry is to ...
LONDON — Cardiogenic shock and recovering cardiac arrest have a checkered history when it comes to high-impact management strategies. Now, a new meta-analysis provides a clear steer on the value of ...
For patients with cardiogenic shock, the in-hospital mortality risk depends on the condition’s etiology—it’s substantially lower when it’s derived from acute decompensated heart failure (HF) than from ...
The use of active mechanical circulatory support is growing rapidly around the world. The hope is that these systems will improve survival after the most severe form of acute heart failure, ...
Most people who've had a heart attack-or who fear having one-focus on surviving the cardiovascular event itself. But what happens in the hours and days after can be just as critical. One serious ...
Please provide your email address to receive an email when new articles are posted on . Cardiogenic shock is a strong independent predictor of in-hospital mortality in children with acute ...
Compared with crushed ticagrelor, intravenous cangrelor provided immediate, effective platelet inhibition, with no increase in major bleeding and lower mortality rates in patients with acute ...
Compared with crushed ticagrelor, intravenous cangrelor provided immediate, effective platelet inhibition, with no increase in major bleeding and lower mortality rates in patients with acute ...